Karah Herdman Parschauer - 06 Mar 2026 Form 4 Insider Report for Ultragenyx Pharmaceutical Inc. (RARE)

Signature
/s/ Karah Parschauer
Issuer symbol
RARE
Transactions as of
06 Mar 2026
Net transactions value
-$208,312
Form type
4
Filing time
10 Mar 2026, 16:51:40 UTC
Previous filing
03 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Parschauer Karah Herdman EVP and Chief Legal Officer C/O ULTRAGENYX PHARMACEUTICAL INC., 60 LEVERONI COURT, NOVATO /s/ Karah Parschauer 10 Mar 2026 0001677455

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RARE Common Stock Sale $128,785 -6,018 -7.9% $21.40 70,328 06 Mar 2026 Direct
transaction RARE Common Stock Sale $79,526 -3,508 -5% $22.67 66,820 10 Mar 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.